openPR Logo
Press release

Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 2 - Pipeline Review: Share, Growth, Trends and Forecast 2017 – 2022

06-20-2017 04:50 PM CET | Health & Medicine

Press release from: Medical Industry Research Reports-[MRH]

Market Research Hub

Market Research Hub

“Ectonucleotide Pyrophosphatas Family” Member 2 (Autotaxin or Extracellular Lysophospholipase D or ENPP2 or EC 3.1.4.39) - Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 (ENPP2) is an enzyme encoded by the ENPP2 gene. It stimulates migration of melanoma cells. It has a role in induction of parturition. It is involved in cell proliferation and adipose tissue development.

Request For Free Sample @ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1157728

Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 2 (Autotaxin or Extracellular Lysophospholipase D or ENPP2 or EC 3.1.4.39) pipeline Target constitutes close to 11 molecules. Out of which approximately 8 molecules are developed by companies and remaining by the universities/institutes. The molecules developed by companies in Phase II and Preclinical stages are 1 and 7 respectively. Similarly, the universities portfolio in Preclinical and Discovery stages comprises 2 and 1 molecules, respectively. Report covers products from therapy areas Oncology, Gastrointestinal, Respiratory, Central Nervous System, Immunology, Musculoskeletal Disorders, Cardiovascular, Genito Urinary System And Sex Hormones and Male Health which include indications Idiopathic Pulmonary Fibrosis, Breast Cancer, Fibrosis, Liver Fibrosis, Lung Cancer, Multiple Sclerosis, Systemic Sclerosis (Scleroderma), Acute Pain, Atherosclerosis, Benign Prostatic Hyperplasia, Brain Ischemia, Chronic Obstructive Pulmonary Disease (COPD), Chronic Pain, Inflammatory Bowel Disease, Melanoma, Metastatic Lung Cancer, Musculoskeletal Pain, Non-Alcoholic Steatohepatitis (NASH), Osteoarthritis Pain, Ovarian Cancer, Thyroid Cancer and Visceral Pain.

The latest report Ectonucleotide PyrophosphatasePhosphodiesterase Family Member 2 - Pipeline Review, H1 2017, outlays comprehensive information on the Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 2 (Autotaxin or Extracellular Lysophospholipase D or ENPP2 or EC 3.1.4.39) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews key players involved in Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 2 (Autotaxin or Extracellular Lysophospholipase D or ENPP2 or EC 3.1.4.39) targeted therapeutics development with respective active and dormant or discontinued projects.

The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the global therapeutic landscape for Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 2 (Autotaxin or Extracellular Lysophospholipase D or ENPP2 or EC 3.1.4.39)
- The report reviews Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 2 (Autotaxin or Extracellular Lysophospholipase D or ENPP2 or EC 3.1.4.39) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 2 (Autotaxin or Extracellular Lysophospholipase D or ENPP2 or EC 3.1.4.39) targeted therapeutics and enlists all their major and minor projects
- The report assesses Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 2 (Autotaxin or Extracellular Lysophospholipase D or ENPP2 or EC 3.1.4.39) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news and deals related to Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 2 (Autotaxin or Extracellular Lysophospholipase D or ENPP2 or EC 3.1.4.39) targeted therapeutics

Browse Full Report With TOC @ http://www.marketresearchhub.com/report/ectonucleotide-pyrophosphatasephosphodiesterase-family-member-2-autotaxin-or-extracellular-lysophospholipase-d-or-enpp2-or-ec-31439-pipeline-review-h1-2017-report.html

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand the targeted therapy areas and indications for Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 2 (Autotaxin or Extracellular Lysophospholipase D or ENPP2 or EC 3.1.4.39)
- Identify the use of drugs for target identification and drug repurposing
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 2 (Autotaxin or Extracellular Lysophospholipase D or ENPP2 or EC 3.1.4.39) development landscape
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 2 (Autotaxin or Extracellular Lysophospholipase D or ENPP2 or EC 3.1.4.39) - Overview
Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 2 (Autotaxin or Extracellular Lysophospholipase D or ENPP2 or EC 3.1.4.39) - Therapeutics Development
Products under Development by Stage of Development
Products under Development by Therapy Area
Products under Development by Indication
Products under Development by Companies
Products under Development by Universities/Institutes
Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 2 (Autotaxin or Extracellular Lysophospholipase D or ENPP2 or EC 3.1.4.39) - Therapeutics Assessment
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 2 (Autotaxin or Extracellular Lysophospholipase D or ENPP2 or EC 3.1.4.39) - Companies Involved in Therapeutics Development
Eli Lilly and Company
Continue….

Make an Enquiry: http://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1157728

About Market Research Hub:

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Details:

90 State Street,
Albany, NY 12207,
United States
Toll Free: 866-997-4948 (US-Canada)
Tel: +1-518-621-2074
Email: press@marketresearchhub.com
Website: http://www.marketresearchhub.com/
Read More Related News: https://www.industrynewsanalysis.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 2 - Pipeline Review: Share, Growth, Trends and Forecast 2017 – 2022 here

News-ID: 587686 • Views:

More Releases from Medical Industry Research Reports-[MRH]

Global Ophthalmic Diagnostic Devices Sales Market Report : Share, Growth, Size, Trends and Forecast 2017 - 2022
Global Ophthalmic Diagnostic Devices Sales Market Report : Share, Growth, Size, …
Market Research Hub (MRH) has recently added a new report to its vast online database. This research study is titled as “Global Ophthalmic Diagnostic Devices Sales Market Report” 2017 which presents an in-depth study about the production, consumption, market volume, revenue (million USD) and market share across different geographical regions. Request For Free Sample - http://www.marketresearchhub.com/enquiry.php?type=S&repid=1324423 Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million
United States Negative Pressure Wound Therapy (NPWT) Market Projections & Upcoming Trends Recorded till 2024
United States Negative Pressure Wound Therapy (NPWT) Market Projections & Upcomi …
 This report on the United States negative pressure wound therapy (NPWT) market is filled with necessary details and facts which provide deep insight into this sector. Further, extensive interviews are conducted with chief opinion leaders (KOLs), physicians and industry experts to authenticate the market size, company share as well as distribution share data and analysis. The report titled “United States Negative Pressure Wound Therapy (NPWT) Market Outlook to 2024”, has been
Global Intraoperative Ultrasound Market, Growth, Analysis, Production, Forecasts Research Report to 2017
Global Intraoperative Ultrasound Market, Growth, Analysis, Production, Forecasts …
To Understand the medical equipments Industry Status worldwide, Market Research Hub (MRH) has included the latest Forecast report titled “Global Intraoperative Ultrasound Market Reports September, 2017” to its vast database. This study offers data about the prime regions operating in the medical equipments sector, along with their production, consumption, revenue and market share details. Further, the intelligent report also anticipates that the market would grow at a constructive CAGR until
Global RFID Medical Inventory Management Systems Market Research Report Share, Growth, Size, Trends and Forecast 2017 - 2022
Global RFID Medical Inventory Management Systems Market Research Report Share, G …
Market Research Hub (MRH) has recently added a new report to its vast online database. This research study is titled as “Global RFID Medical Inventory Management Systems Market Report” 2017 which presents an in-depth study about the production, consumption, market volume, revenue (million USD) and market share across different geographical regions. Request For Free Sample - http://www.marketresearchhub.com/enquiry.php?type=S&repid=1313969 Geographically, this report is segmented into several key Regions, with production,

All 5 Releases


More Releases for Ectonucleotide

Location Intelligence (LI) Market to Witness Notable Growth by 2027 Covid-19 Ana …
This Location Intelligence (LI) market report provides a comprehensive overview of the major aspects that will drive market growth, such as market drivers, constraints, prospects, opportunities, restraints, current trends, and technical & industrial advancements. Industry detailed study, development and enhancement in industrial sector, and new product launches portrayed in this Location Intelligence (LI) market report are of extraordinary assistance for the new significant business market players entering into the market.
Ectonucleotide Pyrophosphatase/Autotaxin Pipeline Review Studied and Analyzed in …
 Occurrence of severe ailments such as fibrosis, sclerosis, cancer, and chronic pain are attributed to altered autotaxin levels. To combat rising fatality induced by aforementioned diseases has motivated healthcare industry to undertake clinical trials for drug development. In its recently added report titled, ‘Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 2 (Autotaxin or Extracellular Lysophospholipase D or ENPP2 or EC 3.1.4.39) - Pipeline Review, H1 2018’, Market Research Hub (MRH) lends clarity on the
Global Ectonucleotide Pyrophosphatase Market Strategies, Industry Verticals and …
Qyresearchreports include new market research report "Global Ectonucleotide Pyrophosphatase Market Research Report 2018" to its huge collection of research reports. The study on the global Ectonucleotide Pyrophosphatase market strives to offer critical and in-depth insights into the current market outlook and emerging growth dynamics. The insights cover the analysis of key factors shaping the various trajectories the market has traversed in recent years. To offer a comprehensive assessment of the prevailing
Global Ectonucleotide Pyrophosphatase Sales Market Analysis Revealing Key Driver …
An up-to-date research has been disclosed by Market Research Hub highlighting the “Global Digital Media Switchers Market Research Report 2018”. The report deep dives into the dynamics of Global Digital Media Switchers Market providing useful and unique insights. The information is shared in a precise and structured manner, giving executives and leaders an accurate picture of the upcoming market movement. The document utilizes a number of monographs, pie charts and
Global Ectonucleotide Pyrophosphatase Market Research 2017 : Eli Lilly and Co, G …
Qyresearchreports include new market research report "Global Ectonucleotide Pyrophosphatase Market Research Report 2017" to its huge collection of research reports. The report here amasses trade perspectives having a place with the global Ectonucleotide Pyrophosphatase market which verbalizes the present-day data and future exposures with reference to the dynamic powers at play. The prime clarification for the examination report is to offer the endorser with a wide framework and make open the
Ectonucleotide Pyrophosphatase Market 2018 : Eli Lilly and Co, Galapagos NV, Ono …
WiseGuyReports.com with their unique quality of simplifying the market research study, presents a deep diving study report “Ectonucleotide Pyrophosphatase - Pipeline Review, H1 2018” Ectonucleotide Pyrophosphatase Overview Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 2 (Autotaxin or Extracellular Lysophospholipase D or ENPP2 or EC 3.1.4.39) - Ectonucleotide Pyrophosphatase/Phosphodiesterase family member 2 (ENPP2) is an enzyme encoded by the ENPP2 gene. It stimulates migration of melanoma cells. It has a role in the induction of parturition. It